Omkar Speciality Chemicals Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Omkar Speciality Chemicals (NSE: OMKARCHEM) is preparing to announce its Q4 FY26 financial results for the quarter ended March 31, 2026. With Omkar Speciality Chemicals trading at Rs 62 — against a 52-week high of Rs 98 and a 1-year return of -28% — the Q4 FY26 results will be a pivotal event for investors in the Specialty Chemicals sector.

Analyst estimates for Q4 FY26 revenue stand at Rs 120–140 Cr, with PAT expectations of Rs 6–10 Cr and margin projections of EBITDA 12–15%. This article covers the Omkar Speciality Chemicals Q4 results 2026 date, detailed earnings estimates, five key performance factors, five risks to monitor, analyst ratings and price targets, and answers to the most commonly searched investor questions.

Get free investment predictions and live Q4 result alerts on Univest.

Omkar Speciality Chemicals Q4 Results 2026 Date

Omkar Speciality Chemicals has scheduled its Q4 FY26 results for May 2026 (Expected). The board of directors will meet on this date to approve the audited financial statements for the quarter ended March 31, 2026, and to consider a final dividend recommendation. At a current market price of Rs 62, investors and analysts are closely watching this announcement for revenue growth confirmation and FY27 guidance.

Why This Quarter Matters

Q4 is the final quarter of the financial year — it determines full-year FY26 performance, sets the FY27 estimate base, and triggers final dividend announcements. For Omkar Speciality Chemicals, which operates in the Specialty Chemicals sector, Q4 FY26 will reveal whether momentum from earlier quarters has been sustained and whether management’s strategic initiatives have translated into financial outcomes.

At a 1-year return of -28%, this quarter’s results and FY27 guidance will be critical in determining whether the stock can begin a recovery. Investors will watch for order pipeline updates, margin trajectory, and capex guidance — any positive surprise on multiple parameters could drive a meaningful post-results re-rating.

Omkar Speciality Chemicals Q4 FY26 Earnings Estimates

Omkar Speciality Chemicals Q4 FY26 Analyst Estimates at a Glance | Source: MOFSL, YES Securities, JM Financial

Access premium SEBI-registered research on Univest.

Analysts covering Omkar Speciality Chemicals have published Q4 FY26 estimates based on Q3 FY26 actuals, sector trends, and company-specific catalysts. Consensus estimates point to revenue of Rs 120–140 Cr, PAT of Rs 6–10 Cr, and margins of EBITDA 12–15%. These projections reflect both the seasonal strength of Q4 and ongoing structural improvements in Omkar Speciality Chemicals’s business model.

Beyond headline numbers, investors will closely monitor FY27 guidance commentary, order book evolution, working capital trends, and any one-time items that could inflate or suppress reported PAT. A clean recurring profit print is more positively received by the market than results driven by non-operational gains.

Screen Omkar Speciality Chemicals fundamentals on Univest Screener.

5 Key Factors That Will Drive Omkar Speciality Chemicals Q4 FY26 Performance

Iodine Derivatives and Pharma Intermediates

Omkar Speciality Chemicals is one of India’s leading manufacturers of iodine-based chemicals and pharma intermediates. Q4 FY26 will reflect demand trends in the global pharmaceutical API and specialty chemical markets. Recovery in global pharma API procurement — after a period of elevated inventory destocking — is a key growth driver.

Export Revenue Recovery

Approximately 40–45% of Omkar’s revenues come from exports to regulated markets in Europe, the US, and Japan. The post-destocking recovery in these markets is expected to drive Q4 FY26 export growth. Analyst estimates build in a 10–15% YoY export revenue recovery based on improving order flows from global pharma customers.

New Product Pipeline and CDMO Potential

Omkar has been exploring contract development and manufacturing (CDMO) opportunities in specialty organics. Any new CDMO wins or long-term supply agreements would provide revenue visibility and improve the margin profile of the business significantly.

Capacity Utilisation Improvement

Omkar’s manufacturing facility in Badlapur (Maharashtra) has been running below optimal utilisation. Q4 FY26 revenue growth toward Rs 140 Cr would improve capacity utilisation and fixed cost absorption, driving EBITDA margins toward the 15% upper end of estimates.

Raw Material Iodine Price Stability

Iodine is a key raw material for Omkar. Iodine prices have historically been volatile due to concentrated global supply from Chile and Japan. Stable iodine prices in Q4 FY26 would support gross margin recovery and improve PAT meaningfully.

5 Risks to Watch in Omkar Speciality Chemicals Q4 FY26

Iodine Price Volatility

Any surge in global iodine prices — due to supply disruptions in Chile — would increase raw material costs significantly and compress Omkar’s gross margins.

Customer Concentration

Omkar’s export revenues are concentrated in a few large pharmaceutical companies. Loss of a key export customer would materially impact revenue.

Regulatory Compliance in Export Markets

Export to regulated markets requires stringent quality compliance. Any FDA or EMA warning letters or import alerts could disrupt export revenues significantly.

Working Capital Intensity

Specialty chemical exports typically have longer credit cycles. Elevated receivables from export customers could strain working capital and increase short-term borrowing.

Competition from Chinese Manufacturers

Chinese specialty chemical manufacturers often compete on price in commodity segments. Any pricing pressure from Chinese competitors could limit Omkar’s ability to improve realisations.

Omkar Speciality Chemicals Share Price and Analyst Ratings

Omkar Speciality Chemicals Share Price & Analyst Ratings | Source: NSE/BSE, Broker Notes

Omkar Speciality Chemicals is trading at Rs 62 as of early April 2026, against a 52-week high of Rs 98 and 52-week low of Rs 50. Market cap stands at Rs 420 Cr. The 1-year return of -28% reflects sector headwinds alongside company-specific factors. Analyst price targets range from the conservative to the optimistic, reflecting differing views on the pace of business recovery and margin expansion.

Download the Univest iOS App or Univest Android App to track Omkar Speciality Chemicals’s live price and receive real-time Q4 result alerts.

Conclusion

Omkar Speciality Chemicals Q4 FY26 results will test whether the global pharma intermediate upcycle is translating into higher revenues and margins. At Rs 62, the stock appears attractively valued relative to its 52-week high of Rs 98. A revenue print above Rs 130 Cr with margin improvement toward 14–15% would be a strong positive catalyst. The key watchpoint is export order visibility — management commentary on this will be critical for FY27 estimates. Consult a SEBI-registered advisor before investing.

This content is published by Univest, a SEBI-registered research and advisory platform. All analyst estimates and price targets cited are from publicly available broker notes. Past performance is not indicative of future results. Investors should conduct independent due diligence before making any investment decisions.

For more Q4 FY26 previews across IT, banking, auto, pharma, and cement sectors, visit Univest Blogs.

Frequently Asked Questions

What is the Omkar Speciality Chemicals Q4 results 2026 date?

Omkar Speciality Chemicals Q4 FY26 results are scheduled for May 2026 (Expected). The board of directors will meet on this date to approve the audited financial statements and consider a dividend recommendation for FY26.

What is the Omkar Speciality Chemicals Q4 FY26 PAT estimate?

Analysts estimate Omkar Speciality Chemicals Q4 FY26 net profit (PAT) in the range of Rs 6–10 Cr. This estimate is based on revenue assumptions of Rs 120–140 Cr and a margin of EBITDA 12–15%. Actual results may differ from these consensus estimates.

What is Omkar Speciality Chemicals’s share price ahead of Q4 results?

Omkar Speciality Chemicals shares are trading at approximately Rs 62 as of early April 2026. The 52-week high is Rs 98 and the 52-week low is Rs 50. The one-year return is -28% and the market cap stands at Rs 420 Cr.

Will Omkar Speciality Chemicals declare a dividend in Q4 2026?

Omkar Speciality Chemicals is expected to consider a dividend of Rs 1–2 per share at the Q4 FY26 board meeting on May 2026 (Expected). The quantum signals management’s confidence in free cash flow generation for FY26.

Which analysts have a Buy rating on Omkar Speciality Chemicals?

YES Securities (target Rs 85) have positive ratings on Omkar Speciality Chemicals ahead of Q4 FY26 results.

What were Omkar Speciality Chemicals Q3 FY26 results?

In Q3 FY26, Omkar Speciality Chemicals reported revenue of Rs 108 Cr and PAT of Rs 5 Cr, with margins at EBITDA 13.1%. These numbers provided the base for Q4 FY26 estimates and analyst coverage updates.

When do Infosys and TCS announce Q4 results 2026?

TCS announced Q4 FY26 results on April 9, 2026. See the full TCS Q4 Results 2026 preview. Infosys announced Q4 FY26 results on April 23, 2026.

Is Omkar Speciality Chemicals a good investment ahead of Q4 results?

Omkar Speciality Chemicals at Rs 62 offers a risk-reward that depends on Q4 execution and FY27 guidance. Investors should review the analyst estimates, monitor the results announcement, and consult a SEBI-registered advisor before making investment decisions. Past performance is not indicative of future results.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

Motisons Jewellers Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Motilal Oswal Financial Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Moschip Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morepen Laboratories Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morarjee Textiles Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook